Related Experiment Video
Updated: Jul 31, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
A comparison of drug interaction software programs: applicability to the emergency department
R M Goldberg1, J Mabee, M Mammone
1Department of Emergency Medicine, Los Angeles County/University of Southern California Medical Center.
Annals of Emergency Medicine
|October 1, 1994
Summary
This study evaluated drug interaction software for emergency departments (EDs). While no program was perfect, many offer useful features for the fast-paced ED environment.
Area of Science:
- Clinical Informatics
- Pharmacology
- Emergency Medicine
Background:
- Effective drug interaction software is crucial for patient safety in emergency settings.
- Emergency departments (EDs) face unique challenges requiring specialized clinical tools.
Purpose of the Study:
- To compare features of available drug interaction software.
- To assess general applicability for emergency department (ED) use.
Main Methods:
- Prospective evaluation of eight commercial drug interaction software programs.
- Assessment based on the presence or absence of key performance features.
- Evaluation conducted in university and community hospital EDs.
Main Results:
- Programs were assessed using predefined performance and database features.
- Tabulated results facilitated direct comparison across software.
- No single program fully met all specific ED needs.
Conclusions:
- Several drug interaction software programs possess features applicable to ED settings.
- Ongoing development may lead to more tailored solutions for emergency care.
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...